{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-23-000058","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2023-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.499940+00:00","generated_at":"2026-06-11T09:46:10.493273+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cardinal Health Q4 non-GAAP EPS $1.55 (+48%); raises FY24 guidance to $6.50-$6.75","bullets":["Q4 revenue $53.5B (+13% YoY); non-GAAP EPS $1.55 (+48%) vs $1.05 prior year.","Pharmaceutical segment profit up 12% to $504M; Medical segment profit improved to $82M from -$16M.","Full-year non-GAAP EPS $5.79 (+14%), an all-time high; operating cash flow $2.8B.","FY2024 non-GAAP EPS guidance raised to $6.50-$6.75 from $6.45-$6.70; segment profit growth expected.","Director Carrie S. Cox will not stand for re-election at 2023 annual meeting; no disagreement."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-23-000058","json":"https://secwatch.observer/filing/0000721371-23-000058.json","markdown":"https://secwatch.observer/filing/0000721371-23-000058.md","text":"https://secwatch.observer/filing/0000721371-23-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/0000721371-23-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/cah-20230810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T09:46:10.493273+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bea70eaab1029ca9b8f5101d64e42a624f46baca","claim":"CARDINAL HEALTH INC reported the quarter and fiscal year ended June 30, 2023 results: revenue $205.0 billion, net income $261 million, EPS $1.00. Guidance raised.","evidence_excerpt":"RELEASE Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance • Fourth quarter revenue increased 13% to $53.5 billion • Fourth quarter GAAP 1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 • Fourth quarter non-GAAP operating earnings increased 24% to $560 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/0000721371-23-000058-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and fiscal year ended June 30, 2023"},{"label":"Revenue","value":"$205.0 billion"},{"label":"Net income","value":"$261 million"},{"label":"EPS","value":"$1.00"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"bea70eaab1029ca9b8f5101d64e42a624f46baca","claim":"CARDINAL HEALTH INC reported the quarter and fiscal year ended June 30, 2023 results: revenue $205.0 billion, net income $261 million, EPS $1.00. Guidance raised.","evidence_excerpt":"Fiscal year 2023 revenues were $205.0 billion","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/0000721371-23-000058-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and fiscal year ended June 30, 2023"},{"label":"Revenue","value":"$205.0 billion"},{"label":"Net income","value":"$261 million"},{"label":"EPS","value":"$1.00"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"cc333881e7","claim":"Carrie S. Cox departed as Director at CARDINAL HEALTH INC.","evidence_excerpt":"On August 10, 2023, Carrie S. Cox, a member of the Board of Directors (the “Board”) of the Company since 2009, informed the Company that she has decided not to stand for re-election to the Board when her term expires at the 2023 annual meeting of shareholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/0000721371-23-000058-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"decided not to stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}